{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": 5.555557, "regularMarketPrice": 0.019, "exchange": "FRA", "shortName": "HEMOGENYX PHARM.PLC LS-01", "longName": "Hemogenyx Pharmaceuticals Plc", "messageBoardId": "finmb_534035013", "exchangeTimezoneName": "Europe/Berlin", "market": "dr_market", "regularMarketTime": 1683880220, "regularMarketDayHigh": 0.019, "regularMarketDayRange": "0.019 - 0.019", "regularMarketDayLow": 0.019, "regularMarketVolume": 1050, "regularMarketPreviousClose": 0.018, "bid": 0.0195, "ask": 0.032, "fullExchangeName": "Frankfurt", "financialCurrency": "GBP", "regularMarketOpen": 0.019, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.011499999, "fiftyTwoWeekLowChangePercent": 1.5333333, "fiftyTwoWeekRange": "0.0075 - 0.05", "fiftyTwoWeekHighChange": -0.031000001, "fiftyTwoWeekHighChangePercent": -0.62, "fiftyTwoWeekLow": 0.0075, "fiftyTwoWeekHigh": 0.05, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.01, "sharesOutstanding": 1142000000, "bookValue": 0.003, "fiftyDayAverage": 0.01728, "fiftyDayAverageChange": 0.0017200001, "fiftyDayAverageChangePercent": 0.099537045, "twoHundredDayAverage": 0.0141325, "twoHundredDayAverageChange": 0.0048674997, "twoHundredDayAverageChangePercent": 0.34441888, "marketCap": 28056348, "priceToBook": 6.333333, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1596693600000, "priceHint": 4, "regularMarketChange": 0.0010000002, "symbol": "5HU.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "60 Gracechurch Street", "address2": "6th Floor", "city": "London", "zip": "EC3V 0HR", "country": "United Kingdom", "phone": "44 79 0917 7311", "website": "https://www.hemogenyx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. The company was founded in 2012 and is headquartered in London, the United Kingdom.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Dr. Vladislav  Sandler Ph.D.", "title": "Co-Founder, CEO & Director", "fiscalYear": 2021, "totalPay": {"raw": 268605, "fmt": "268.61k", "longFmt": "268,605"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Alexis M. Sandler J.D.", "title": "Independent Co-Founder & Non-Exec. Director", "fiscalYear": 2021, "totalPay": {"raw": 56747, "fmt": "56.75k", "longFmt": "56,747"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andrew  Wright", "title": "Financial Controller & Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Koen  Van Besien M.D., Ph.D.", "title": "Clinical Advisor & Medical Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}